JP2023526218A5 - - Google Patents

Info

Publication number
JP2023526218A5
JP2023526218A5 JP2022568638A JP2022568638A JP2023526218A5 JP 2023526218 A5 JP2023526218 A5 JP 2023526218A5 JP 2022568638 A JP2022568638 A JP 2022568638A JP 2022568638 A JP2022568638 A JP 2022568638A JP 2023526218 A5 JP2023526218 A5 JP 2023526218A5
Authority
JP
Japan
Application number
JP2022568638A
Other languages
Japanese (ja)
Other versions
JP7834347B2 (ja
JP2023526218A (ja
JPWO2021228052A5 (https=
Filing date
Publication date
Priority claimed from CN202010393721.9A external-priority patent/CN113637084B/zh
Application filed filed Critical
Publication of JP2023526218A publication Critical patent/JP2023526218A/ja
Publication of JP2023526218A5 publication Critical patent/JP2023526218A5/ja
Publication of JPWO2021228052A5 publication Critical patent/JPWO2021228052A5/ja
Priority to JP2025209848A priority Critical patent/JP2026035742A/ja
Application granted granted Critical
Publication of JP7834347B2 publication Critical patent/JP7834347B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022568638A 2020-05-11 2021-05-10 生体高分子標的特異的補体阻害剤及びその製造方法と応用 Active JP7834347B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025209848A JP2026035742A (ja) 2020-05-11 2025-11-28 生体高分子標的特異的補体阻害剤及びその製造方法と応用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010393721.9 2020-05-11
CN202010393721.9A CN113637084B (zh) 2020-05-11 2020-05-11 生物大分子靶向特异性补体抑制剂及其制备方法与应用
PCT/CN2021/092861 WO2021228052A1 (zh) 2020-05-11 2021-05-10 生物大分子靶向特异性补体抑制剂及其制备方法与应用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025209848A Division JP2026035742A (ja) 2020-05-11 2025-11-28 生体高分子標的特異的補体阻害剤及びその製造方法と応用

Publications (4)

Publication Number Publication Date
JP2023526218A JP2023526218A (ja) 2023-06-21
JP2023526218A5 true JP2023526218A5 (https=) 2025-06-17
JPWO2021228052A5 JPWO2021228052A5 (https=) 2025-06-17
JP7834347B2 JP7834347B2 (ja) 2026-03-24

Family

ID=78415417

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022568638A Active JP7834347B2 (ja) 2020-05-11 2021-05-10 生体高分子標的特異的補体阻害剤及びその製造方法と応用
JP2025209848A Pending JP2026035742A (ja) 2020-05-11 2025-11-28 生体高分子標的特異的補体阻害剤及びその製造方法と応用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025209848A Pending JP2026035742A (ja) 2020-05-11 2025-11-28 生体高分子標的特異的補体阻害剤及びその製造方法と応用

Country Status (6)

Country Link
US (1) US20230348554A1 (https=)
EP (1) EP4151659A4 (https=)
JP (2) JP7834347B2 (https=)
CN (2) CN113637084B (https=)
CA (1) CA3178088A1 (https=)
WO (1) WO2021228052A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114920849A (zh) * 2022-03-09 2022-08-19 安徽省立医院(中国科学技术大学附属第一医院) 一种靶向补体免疫抑制蛋白及其构建方法及应用
WO2025103318A1 (zh) * 2023-11-13 2025-05-22 沈阳三生制药有限责任公司 一种靶向C3b的双功能融合蛋白及其制备方法与用途
CN121159642B (zh) * 2025-11-20 2026-04-03 山东第二医科大学 补体c9迷你结合蛋白或其突变体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
EP3524620A1 (en) * 2008-10-14 2019-08-14 Genentech, Inc. Immunoglobulin variants and uses thereof
CN104231085B (zh) * 2013-09-05 2017-03-15 复旦大学附属肿瘤医院 靶向特异性补体系统抑制剂、其制备方法及应用
WO2017114401A1 (zh) * 2015-12-31 2017-07-06 江苏匡亚生物医药科技有限公司 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用
WO2019075519A1 (en) * 2017-10-18 2019-04-25 Csl Limited HUMAN SERUM ALBUMIN VARIANTS AND USES THEREOF
SI3793586T1 (sl) * 2018-05-16 2024-07-31 Csl Limited Različice receptorja za topni komplement tipa 1 in njihova uporaba
WO2020041644A1 (en) * 2018-08-22 2020-02-27 Alexion Pharmaceuticals, Inc. Fusion proteins and methods of treating complement dysregulation using the same
CN111018999B (zh) * 2019-12-05 2022-07-12 沣潮医药科技(上海)有限公司 二聚体免疫融合蛋白、药物组合物和用途

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)